At Town & Country Compounding, we specialize in compounding bioidentical hormones (BHRT) for women.
Misguided legacy of hormone replacement therapy
The Women’s Health Initiative (WHI), a landmark study halted in 2002, significantly impacted how menopause symptoms have been mismanaged in the past twenty-plus years. While it may be an oversimplification to attribute all menopausal suffering to this study, its findings instilled a deep-seated fear among healthcare providers regarding hormone replacement therapy (HRT).
Concerns about increased risks of breast cancer, heart disease, and strokes led to many doctors hesitating to prescribe HRT, denying countless women the opportunity to alleviate debilitating menopausal symptoms. As a result, women faced hot flashes, night sweats, mood swings, and sleep disturbances in silence, negatively affecting their quality of life and overall well-being.
Following the publication of the WHI results in 2002, the use of HRT fell from 29% in 2001 to 10–11% in 2005 among women aged 50–74 in the UK. A significant decline in use was also observed in the USA (46%) and Canada (28%), among other countries.
Source: Maturitas
A generation of doctors misled about HRT
In the aftermath of the WHI, medical education shifted, teaching the next generation of physicians that HRT posed significant dangers. This gap in knowledge has left many healthcare providers ill-equipped and very hesitant to offer HRT as management for menopause and hormonal health. Consequently, women have often been deprived of the relief they deserve, as outdated information continues to influence care decisions.
Women were often led to believe by their healthcare providers that HRT was a blanket risk rather than a personalized option. This misconception caused many doctors to avoid prescribing therapy and patients to shy away from asking for what could have provided substantial symptom relief.
Listen to a woman’s experience as perimenopausal symptoms were invalidated
The shift towards comprehensive care
In light of evolving research, healthcare providers are now reassessing their approach to HRT. New research discussions suggest that, when initiated at the appropriate time and carefully managed, HRT may be a beneficial option for many women. However, the stigma and misunderstandings stemming from the WHI still linger, making it crucial to continue educating both patients and providers.
HRT and quality of life: a missed opportunity for patient-centered care
While there has been progress, many women still feel their symptoms and quality of life have not been prioritized.
The hesitancy surrounding HRT has led to a widespread lack of medications and therapies for addressing menopausal symptoms, forcing women to endure persistent hot flashes, mood fluctuations, and sleep disruptions that could have been alleviated with appropriate care.
The one-size-fits-all mentality surrounding HRT has often sidelined individual women’s needs and preferences. Open discussions about the specific benefits and risks of HRT based on each woman’s unique health situation have been sorely lacking.
The role of bioidentical hormones: BHRT for women
As understanding of HRT continues to evolve, bioidentical hormones are gaining recognition. Unlike synthetic alternatives, bioidentical hormones are chemically identical to those produced by the body. This personalization allows for a more tailored approach to hormone therapy, potentially helping women to find relief that aligns with their specific needs.
Prescribers:
Women, Wellness & Wine: Building a supportive community
Understanding the unique challenges women face during menopause, Town & Country Compounding hosts events like “Women, Wellness & Wine.”
These monthly gatherings of up to 20 women provide a nurturing space for women to connect, share their experiences, and seek guidance.
Led by women’s health expert Pharmacist Jari Becker, these meetings foster community and allow participants to engage openly about menopause and other health concerns.
